Company Filing History:
Years Active: 2020
Title: Innovations of Guangyan Li in Hematology
Introduction
Guangyan Li is a notable inventor based in Linyi, China, recognized for his contributions to the field of hematology. He holds two patents that focus on the use of icaritin in the prevention and treatment of hematocytopenia. His work is significant in addressing conditions related to bone marrow suppression and thrombocytopenia.
Latest Patents
Li's latest patents include methods for utilizing icaritin to prepare medicaments aimed at preventing or treating hematocytopenia. The applications detail how icaritin can be effective in preventing or treating bone marrow suppression caused by chemotherapeutic drugs. Additionally, it highlights the potential of icaritin in managing thrombocytopenia, including immune thrombocytopenia.
Career Highlights
Guangyan Li is affiliated with Lunan Pharmaceutical Group Corporation, where he applies his expertise in pharmaceutical innovations. His work has contributed to advancements in medical treatments, particularly in hematology.
Collaborations
Li collaborates with esteemed colleagues such as Zhiquan Zhao and Jingchun Yao, enhancing the research and development efforts within his field.
Conclusion
Guangyan Li's innovative work in the application of icaritin represents a significant advancement in the treatment of hematological conditions. His contributions continue to impact the medical community positively.